Sound Equity Income ETF (SDEI), now known as Sound Equity Dividend Income ETF (DIVY) since July 24, 2023, is an actively managed exchange-traded fund that seeks current income via a dividend yield targeted at least twice that of the S&P 500 Index and long-term capital appreciation. The fund invests primarily in common stocks of dividend-paying mid- and large-capitalization U.S. companies selected for sound economic foundations, positive cash flows, profitability, undervaluation, and growth potential; it typically holds approximately 30 securities diversified across ten market sectors while avoiding tobacco companies to mitigate legal risks and favoring tax-efficient qualified dividends. DIVY operates within the equity income segment, targeting income-seeking investors such as retirees and risk-averse individuals through broker-dealers, investment advisors, and financial services firms.
Launched on December 30, 2020, as part of the Tidal ETF Trust and listed initially on NYSE Arca, the fund is advised by Toroso Investments, LLC (now at 234 West Florida Street, Suite 203, Milwaukee, Wisconsin 53204) with sub-advisory services from Sound Income Strategies, LLC, a Fort Lauderdale, Florida-based registered investment advisor founded in 2014. In June 2024, DIVY (along with sister fund Sound Enhanced Fixed Income ETF, FXED) completed a transfer of its primary listing to the floor of the New York Stock Exchange from NYSE Arca, enhancing trading visibility and accessibility for investors. The fund continues monthly distributions, including $0.0390 declared on September 17, 2025, and has seen institutional ownership growth in Q4 2024, with Sound Income Strategies increasing its stake by over 34,000 shares.
DIVY maintains a 0.45% expense ratio and focuses on U.S. equity markets without specified international operations, complementing Sound Income Strategies' broader offerings like FXED for fixed income exposure. No major acquisitions, funding rounds, or strategic alliances beyond sub-advisory and listing changes have been reported in the last 1-2 years.